Skip to main content
. Author manuscript; available in PMC: 2022 Mar 18.
Published in final edited form as: Dev Cell. 2021 Aug 4;56(17):2427–2439.e4. doi: 10.1016/j.devcel.2021.07.009

Figure 2. Transient inhibition of Mps1 accelerates the acquisition of drug resistance in multiple genetic backgrounds.

Figure 2.

(A) Relative abundance of A375 cell populations +/− paclitaxel. See also Figures S2E-F.

(B) Relative abundance of Colo205 cell populations +/− vemurafenib, or +/− paclitaxel. See also Figure S2H.

(C) Relative abundance of RPE1 cell populations +/− paclitaxel. See also Figure S2G.